UNSPSC 51162726: Guaietolin

This classification denotes an expectorant with the molecular formula C11H16O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) G9J54386JH, chemically known as 1,2-propanediol, 3-(o-ethoxyphenoxy)- but more generally known as guaietolin, which bears US NIH Compound Identifier 68825. European Medicines Agency schedules Guaietolin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07972MIG.

UNSPSC 51162726 Guaietolin (Commodity) represents pharmaceutical and medical products state and local governments procure for correctional facilities, public health departments, and emergency-response programs, though recent solicitation activity shows the code capturing a mixed scope that diverges from the nominal commodity description. The Washington State Department of Corrections' RFQQ RFQQK13020 (due October 7, 2026) solicits parenteral products, services, and equipment — specifically total parenteral nutrition solutions, intravenous solutions, and controlled substances for incarcerated individuals — with an emphasis on delivery speed and specialized preparation expertise. A parallel Seminole County, Florida IFB (IFB60459723LAS, posted June 30, 2026) procures naloxone and safe drug deactivation systems for community health initiatives, reflecting the code's application across correctional and public-health contexts. The issuing bodies include state departments of corrections and county health authorities; the Washington solicitation explicitly encourages small business (25%), minority-owned business (10%), women-owned business (6%), and veteran-owned business (5%) participation under state set-asides and requires documented experience in parenteral preparation, patient monitoring, and 24-hour delivery compliance.

Activity under this code concentrates in Washington state and Florida, with the Washington DOC opportunity spanning eight facilities across three geographic regions (West, Central, and East) and anticipating awards to up to three contractors per region through June 30, 2030. The Washington solicitation imposes firm pricing for the initial two-year contract term and requires Commercial General Liability ($1 million per occurrence), Professional Liability ($2 million per occurrence), Business Automobile Liability ($1 million per occurrence), and Cyber Liability ($2 million per occurrence) coverage, with DOC and the State of Washington as additional insureds. The Seminole County procurement calls for 1,900 units of naloxone and 800 deactivation systems annually on a two-year initial contract with one-year renewal option, with quarterly deliveries to a single health facility and potential FEMA funding triggering federal compliance requirements. Given the mismatch between the nominal commodity name and the actual pharmaceutical and medical-service scope, validation of this code's applicability to your competitive position is warranted before pursuing opportunities tagged under it.